Boons, Christel C. L. M. http://orcid.org/0000-0003-0202-3612
Timmers, Lonneke
Janssen, Jeroen J. W. M.
Westerweel, Peter E.
Blijlevens, Nicole M. A.
Smit, Willem M.
Bartelink, Imke H.
Wilschut, Janneke A.
Swart, Eleonora L.
Hendrikse, N. Harry
Hugtenburg, Jacqueline G.
Funding for this research was provided by:
Novartis Pharma (CAMN107ENL04T)
Article History
Received: 11 October 2019
Accepted: 22 May 2020
First Online: 2 June 2020
Compliance with ethical standards
: The study was approved by the Medical Ethics review board of the Amsterdam University Medical Centers (location VUmc, Amsterdam)(2013.035), as well as the ethical boards of each participating center (Albert Schweitzer Hospital Dordrecht, Medical Spectrum Twente Enschede, University Medical Centre Groningen, University Medical Centre Utrecht, and Radboudumc Nijmegen). All procedures performed were in accordance with the ethical standards of the Medical Ethics review board and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
: J.J.W.M. Janssen is an advisory board member for Abbvie, Incyte, Jazz Pharmaceuticals, and Pfizer, and has received research support funding from Novartis and Bristol Myers Squibb and speaker’s fees from Incyte and Pfizer. P.E. Westerweel has been an advisory board member for Novartis and has received research support funding from Novartis. N.M.A. Blijlevens has received funding of Novartis, Bristol Myers Squibb, Pfizer, and Incyte for web-based platform CMyLife. W.M. Smit has been an advisory board member for Roche and Novartis. The other authors declare no conflict of interest.